AbbVie
ABBV
#26
Rank
โ‚ฌ343.19 B
Marketcap
194,18ย โ‚ฌ
Share price
-1.15%
Change (1 day)
19.65%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ115.00 Billion

According to AbbVie's latest financial reports the company's total assets are โ‚ฌ115.00 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ129.88 B6.59%
2023-12-31โ‚ฌ121.85 B-5.83%
2022-12-31โ‚ฌ129.40 B0.01%
2021-12-31โ‚ฌ129.38 B5.7%
2020-12-31โ‚ฌ122.41 B53.88%
2019-12-31โ‚ฌ79.55 B53.33%
2018-12-31โ‚ฌ51.88 B-12.06%
2017-12-31โ‚ฌ58.99 B-6.12%
2016-12-31โ‚ฌ62.84 B29.52%
2015-12-31โ‚ฌ48.51 B114.47%
2014-12-31โ‚ฌ22.62 B7%
2013-12-31โ‚ฌ21.14 B3.55%
2012-12-31โ‚ฌ20.41 B35.83%
2011-12-31โ‚ฌ15.03 B-5.4%
2010-12-31โ‚ฌ15.88 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚ฌ179.27 B 55.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ83.21 B-27.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ98.71 B-14.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ77.42 B-32.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ50.27 B-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ25.08 B-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ70.82 B-38.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚ฌ98.30 B-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ3.66 B-96.81%๐Ÿ‡บ๐Ÿ‡ธ USA